

Phone (Mobile)
+1 732 ❅❅❅ ❅❅❅❅
Phone (Mobile)

Phone (HQ)
(908) 740-4000
Phone (HQ)

❅❅❅❅❅@cs.com

Office Address (HQ)
126 E Lincoln Ave, Rahway, New Jersey, 07065, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Ed Bajwa
According to Datanyze information, these are Ed Bajwa's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 732 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(908) 740-4000
Phone (HQ)
❅❅❅❅❅@cs.com
Office Address (HQ)
126 E Lincoln Ave, Rahway, New Jersey, 07065, United States
Office Address (HQ)
Ed Bajwa works as a Executive Director, Translational Medicine at Merck & Co, which is a Manufacturing company with an estimated 73 K employees; and founded in 1891. They are part of the Medicine team within the Medical & Health Department and their management level is Director. Ed used to work at Harvard University and Massachusetts General Hospital and have used the following emails: , @merck.com, @msd.com.
Quickly connect with Ed before someone else does! 👏
Ed Bajwa's career began less then a year ago. Prior to joining Merck & Co, Ed worked at 4 companies.
Senior Principal Scientist and Clinical Director, Translational Pharmacology
Assistant Professor of Medicine
Director, Medical ICU
Fellow In Pulmonary and Critical Care Medicine
Merck & Co
126 E Lincoln Ave, Rahway, New Jersey, 07065, United States
73 K
$63.9 B
Manufacturing, Pharmaceuticals
Get Full Profile Access
Ice Breakers
Imagine you could know all about Merck & Co - Ed Bajwa’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Ed’s company in the news
Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers
July 18, 2025
Microfiltration Membranes Company Evaluation Report 2024-2025 | Merck and Veolia Lead in Microfiltration Market with Strategic Moves
July 18, 2025
Merck & Co., Inc. (MRK) Presents at HIV Investor Event Transcript
July 17, 2025
See more
Insights to Break the Ice
In your first interaction
Ed’s CEO is Robert Davis
Merck & Co’s Funding
Last funding
$5B
March 5, 2019
Total raised
$20B
Work Colleague
See Ed Bajwa's coworkers out of Merck & Co's 73 K employees